chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Child woke up completely lethargic, sweaty, trembling and with eyes rolling in the back of her head.  She was rushed to the ED where it was immediately indicated that she was in a hypoglycemic state       (with a blood sugar of 39). She had mild metabolic acidosis on presentation. Preliminary blood work was done, however doctor never thought to test the insulin level. Dextrose bolus was administered and blood sugar spiked to 357. Child was placed on a 12 hour fast, as per the endocrinologist, and was intermittently tested for blood sugar. It never dropped again during the fast. All remaining blood work was unremarkable. Child was discharged the following day. Doctors claim that the sequence of events were idiopathic.
Patient getting 3rd Covid vaccine. After receiving vaccine patient reports tingling in tongue, lips swelling, and roof of mouth feeling numb. Upon assessing there were no visible swelling observed. Patient denies difficulty breathing, and throat swelling. Benadryl 25mg PO given, vitals assessed and WNL. Patient closely monitored by nurse. Patient stated felt fine after therapy.
four days after second shot, severe stomach pain, fevers, trouble urinating, chest pain, . turned into kidney infection, blood infection and having AFIB, need for pace paker.
Hives and itching over entire body starting at about 10 am on 11/28/2021 and continuing into 11/29/2021 Took Benadryl at midnight on 11/29/2021 which seemed to reduce itching
Information title the age of autism pox part 1 has been received, concerning a 12 month old male with a history of a stubborn and severe case of roseola who was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. Concomitant therapy that day included a dose of varicella virus vaccine live. Subsequently, four days after the injection, the patient became ill with a fever and lay limp in his mothers arms for the first time in his life. It was noted that he began having chronic diarrhea and by his 15 month old checkup he had regressed so drastically that his pediatrician suggested he could be autistic. The physician agreed to the parents request for an immediate neurodevelopmental evaluation, which resulted in a diagnosis if full syndrome autism. No additional information was provided. Upon internal review, autism was considered an other medical event (OMIC). No additional information was provided.
Parents reported that the client fainted and was unconscious. She had to be transported to ER via EMS and was hospitalized for 6 hours.
Patient states she had a severe reaction starting 2 days after the flu vaccine(given 11-4-06). Patient states having fever of 100.9 , severe pain, shooting pains all over her body including right leg, left arm, chest , head and ear. Patient reports a diagnosis of cellulitis in elbow with Keflex given by 1 of the 2 doctors she saw. Patient is still undergoing treatment at this time.
Fainting; This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (Fainting) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. not provided) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SYNCOPE (Fainting) (seriousness criterion medically significant). At the time of the report, SYNCOPE (Fainting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products were not reported.  No treatment information was provided by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
15 minutes, post vax, the mother stated that the pt had "shivering" for about 30 seconds, alert but stared off for several seconds. No fever. Alert just after. Had a 2nd episode, 3 hours later. She was seen at the office and had episode. MD at bedside but did not note any shaking. Pt was looking off for several seconds but very alert. Neuro exam was normal.
dose of the Moderna Covid-19 Vaccine were given past the beyond use date of 15Jan2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose of the Moderna Covid-19 Vaccine were given past the beyond use date of 15Jan2022) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose of the Moderna Covid-19 Vaccine were given past the beyond use date of 15Jan2022). On 19-Jan-2022, EXPIRED PRODUCT ADMINISTERED (dose of the Moderna Covid-19 Vaccine were given past the beyond use date of 15Jan2022) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided. No treatment medication was provided. The vial was initially stored in the refrigerator on 16-Dec-2021. The vial didn't undergo any temperature excursions.
developed 'bursitis' pain shoulder/neck area since #1 shot, continued to present date had first, second & booster final done 1/4/2022
A non-used report of expired FluMist administered was received from  a patient. Neither medical history nor concomitant medication have been reported. On 01-Nov-2008 and 02-Nov-2008, seventy military personnel, including this patient, received expired FluMist vaccine. The vaccine had an expiration date of March 2009. There was no adverse event associated with this medication error; treatment and reporter / sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customer not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors occurred shortly after the product expired. Follow up information was received on 09-Apr-2009: Product complaint Investigation results.
Information has been received from a family nurse practitioner (FNP), the consumer, a mid thirties year old female who on an unspecified date was vaccinated with first dose of Gardasil (lot # not reported). Subsequently, the patient experienced stinging after the vaccination. The patient also reported that her arm was sore and stung more after the second and third vaccination with Gardasil. The patient sought medical attention. At the time of reporting, the patient had recovered. No other information was available at the time of reporting. Additional information has been requested. 07/06/07 This is in follow-up to report(s) previously submitted on 3/14/2007. Information has been received from a family nurse practitioner (FNP), the consumer, a mid thirties year old female who in August 2006 was vaccinated with first dose of GARDASIL (lot # not reported). The second dose of GARDASIL (lot # not reported) was given October 2006 and the third dose of GARDASIL (lot # not reported) was given February 2007. Subsequently, the patient experienced stinging after the vaccination. The patient also reported that her arm was sore and stung more after the second and third vaccination with GARDASIL. She had no reaction with the first injection which was the pre-loaded syringe. The second and third injection was from a vial. The patient sought medical attention. The sore arm lasted about 3 days. At the time of reporting, the patient had recovered.
Patient reports rash a few hours following vaccine, went to doctor for a steroid shot and medication.
arm itchy; arm red; severe headache; arm hot; delayed reaction; arm swelled; fogginess; diarrhea; joint swelling; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (fogginess), SKIN REACTION (delayed reaction), DIARRHOEA (diarrhea), JOINT SWELLING (joint swelling) and PERIPHERAL SWELLING (arm swelled) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroid disorder (.). Concurrent medical conditions included Cancer and Hypertension (Medical history reported as blood pressure.). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced VISION BLURRED (fogginess), DIARRHOEA (diarrhea) and JOINT SWELLING (joint swelling). On 20-Feb-2021, the patient experienced SKIN REACTION (delayed reaction), PERIPHERAL SWELLING (arm swelled), VACCINATION SITE WARMTH (arm hot) and HEADACHE (severe headache). On an unknown date, the patient experienced VACCINATION SITE REACTION (arm itchy) and VACCINATION SITE ERYTHEMA (arm red). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at an unspecified dose and frequency. On 14-Feb-2021, VISION BLURRED (fogginess), DIARRHOEA (diarrhea) and JOINT SWELLING (joint swelling) had resolved. At the time of the report, SKIN REACTION (delayed reaction), PERIPHERAL SWELLING (arm swelled), VACCINATION SITE REACTION (arm itchy), VACCINATION SITE WARMTH (arm hot), VACCINATION SITE ERYTHEMA (arm red) and HEADACHE (severe headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications High blood pressure medication, thyroid medication, water pill.
seen by MD angioedema of eye, lips, tearing, wheezing, bilat;given epi
Little fever with the first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Little fever with the first vaccine) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Cataract.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Little fever with the first vaccine). At the time of the report, PYREXIA (Little fever with the first vaccine) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-024075 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Additional information received suspect onset date and reporter contact details updated.
Headache, Myalgia, Arthralgia, Fever, DIMINISHED TASTE-RESOLVED Narrative:
11JUL95 vax site became reddened, swollen today 12JUL appears to be like a large hive-sl raised area; c/o pain & discomfort; mom gave APAP & Motrin & ice pack to area; mom will call MD & cont w/APAP & ice pack & give DPH for hives;
Fever, headaches, vomiting, diarrhea, chest pain and difficulty breathing, coughing, fatigue, and muscle pain all through the body not just the injection site.
Side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medication were reported no treatement of medication were reported
Fatigue, jaundice pruritis, elevated liver enzymes.  Diagnosis: idiopathic hepatitis.
tested positive both with a rapid and standard test; tested positive both with a rapid and standard test; This is a spontaneous report from contactable consumer. A 92-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number unknown), via an unspecified route of administration on 04Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient who was in a nursing home received the vaccine first dose on 04Jan2021. On 10Jan2021, he tested positive both with a rapid and standard test. His fever at the highest was 100.3 and he had chills and a cough but that's all gone now. Thought maybe it's because he received the vaccine. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Pt returned at 1300 today (2-27-14) with pink blanching macular rash to legs, abdomen and arms. Otherwise well appearing and afebrile. Suspect reaction to MMR vaccine. Will give 3/4 tsp BENADRYL Q6h until rash gone.
Swollen lymph nodes like under his arm and just a little bit of tenderness; Swollen lymph nodes like under his arm and just a little bit of tenderness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the parent.  A 17-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02May2021 (Lot number: EW0167) at the age of 17 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Allergies" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, Lot number: EW0158), for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious), LYMPH NODE PAIN (non-serious) all with onset May2021, outcome "unknown" and all described as "Swollen lymph nodes like under his arm and just a little bit of tenderness". Therapeutic measures were taken as a result of lymphadenopathy, lymph node pain.  Additional information: Reporter stated, It was the second shot that the patient got on Sunday (Clarified as 02May). The patient received the Pfizer vaccine, and he had the swollen lymph nodes like under his arm and just a little bit of tenderness and the reporter was just wondering how long the effect last or have to look anything in addition to that. Treatment in response to event was reported as he was given Tylenol yesterday, 500 mg tablet, once a day.  No follow-up attempts are possible. No further information is expected.
Severe shoulder and hip pain; walking with a limp; This is a spontaneous report from a non-contactable nurse, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 05Aug2021 at 17:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received sulfur (MANUFACTURER UNKNOWN) for an unknown indication on unknown date and experienced drug allergy. On 13Aug2021 at 12:00, the patient experienced severe shoulder and hip pain and currently walking with a limp. On 12Aug2021, the patient underwent COVID-19 virus test via nasal swab and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events severe shoulder and hip pain and currently walking with a limp was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
No reaction to first shot. Received the second shot the morning of 18 Feb, noticed some minor joint stiffness, minor pain and tiredness mid morning 19 Feb. Laid down at 16:30 and remained asleep until 0530 the next day. Unusual to sleep 13 hours. Later that weekend I noticed a bruise on my leg. I rarely bruise and had not hit my leg on anything. I ignored the bruise a couple weeks, but as it did not heal, continued to hurt and had swelling I went to my primary doctor on 4 March who thought it was a blood clot and sent me for imaging. They determined it was superficial thrombophlebitis and treated with antibiotics and heat.
Client reports chest tightness after receiving the vaccine.  Fire Rescue assessed client.  Vitals wnl.  Per Fire Rescue, no further evaluation needed.  Client releases at 10:10am.
Patient got a COVID vaccine 10/9/23 and then signed up for it again on 10/25/23 and got another dose of it. She states she has a sore arm, but says it's typical side effect for her.
Infant developed intussusception on 06/01/2018. Vaccines administered 05/24/2018. Baby required open laparotomy to correct.
Felt all shaky; Discomfort in my armpit; Discomfort in my chest; Discomfort in my back; Nervous; Discomfort in my shoulder blade; Yawning more than usual; Tired; Little nauseous; little discomfort on her shoulder blade; Tingling in my left arm; Numbness in my left arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in my left arm), HYPOAESTHESIA (Numbness in my left arm), TREMOR (Felt all shaky), LIMB DISCOMFORT (Discomfort in my armpit) and CHEST DISCOMFORT (Discomfort in my chest) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 28-Jan-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced TREMOR (Felt all shaky), LIMB DISCOMFORT (Discomfort in my armpit), CHEST DISCOMFORT (Discomfort in my chest), MUSCULOSKELETAL DISCOMFORT (Discomfort in my back ), NERVOUSNESS (Nervous) and NAUSEA (Little nauseous). On 28-Jan-2021, the patient experienced PARAESTHESIA (Tingling in my left arm) and HYPOAESTHESIA (Numbness in my left arm). On an unknown date, the patient experienced MUSCULOSKELETAL DISCOMFORT (Discomfort in my shoulder blade), YAWNING (Yawning more than usual), FATIGUE (Tired) and MUSCULOSKELETAL DISCOMFORT (little discomfort on her shoulder blade). At the time of the report, PARAESTHESIA (Tingling in my left arm) and HYPOAESTHESIA (Numbness in my left arm) was resolving, TREMOR (Felt all shaky), LIMB DISCOMFORT (Discomfort in my armpit), NERVOUSNESS (Nervous), MUSCULOSKELETAL DISCOMFORT (Discomfort in my shoulder blade), YAWNING (Yawning more than usual), FATIGUE (Tired), NAUSEA (Little nauseous) and MUSCULOSKELETAL DISCOMFORT (little discomfort on her shoulder blade) outcome was unknown, CHEST DISCOMFORT (Discomfort in my chest) had not resolved and MUSCULOSKELETAL DISCOMFORT (Discomfort in my back ) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The pharmacist told her to take a Tylenol. No concomitant medication reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jan-2021: No specific follow-up information recorded.
approx 10 minutes p/inject pt exp lightheadedness & rapid heartrate of 140 per minute; BP 174/82; baseline vital signs were Bp 140/78, P72; no rash; hives or SOB noted; lungs clear; p/20 minutes VS returned to baseline status;
12/24/2020 arm pain at injection site, body aches, mild headache, fatigue; 12/25/2020 symptoms worsened next day; 12/26/2020 loose stools, with continued previous symptoms, dizziness, weakness.;12/27/2020 Covid Test - Negative; 12/28/2020 sore throat, head congestion -- all other symptoms continue to persists.
"During monitoring period post Pfizer COVID-19 vaccine, patient experienced slight throat tightness and tingling in tongue reported to EMS. Given benadryl 12.5mg by mouth. Patient symptoms improved and went home.
pt had a positive COVID test on 8/16/21;  post-mortem testing from Medical Education Research Institute; pt died at Hospital.
This case reported by a medical assistant and described the occurrence of injection site cellulitis in a 15 month old female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed (Infanrix).  On 06/29/2004, the patient received the fourth dose of Infanrix (DTPA614A9) in the left arm.  Approximately two days following the administration of Infanrix, on 07/01/2004, the patient developed cellulitis at the injection site that was characterized as a red, raised area that was painful.  The reaction extended to involve the entire deltoid area.  The patient was seen at a physician's office and treated with Augmentin.  The medical assistant said that the patient did not come in for a re-check so she felt that the patient was ok.  The medical assistant considered the injection site reaction to probably be related to vaccination with Infanrix and a problem with the specific lot number of Infanrix.  Subsequently she stated that the injection site cellulitis was possibly related to vaccination with Infanrix.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients. The pharmacist reported on unspecified dates, an unspecified number of patients were vaccinated with ZOSTAVAX and PNEUMOVAX 23 less than four weeks apart. The pharmacist reported all doses ZOSTAVAX were administered subcutaneously and all doses of PNEUMOVAX 23 were administered intramuscularly. No adverse effect reported. No additional information provided. Additional information has been requested.